ORGENESIS INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-12-10: Form 8-K; Period of report 2012-12-03; Description 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
- 2012-11-27: Form 8-K; Period of report 2012-11-14; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2012-11-09: Form 8-K; Period of report 2012-10-30; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2012-10-09: Form 8-K; Period of report 2012-10-05; Description 1.02 Termination of a Material Definitive Agreement.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2012-12-10 | 8-K | 2012-12-03 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 The disclosure under Item 3.02 of this current report on Form 8-K is responsive to this Item and is hereby incorporated by reference. 1.02 The disclosure under Item 3.02 of this current report on Form 8-K is responsive to this Item and is hereby incorporated by reference. 3.02 On December 3, 2012 we entered into a Cancellation and Amendment Agreement with Derby Management LLC to cancel 500,000 warrants and amend the terms of 200,000 warrants currently held by Derby. | form8k.htm |
| 2012-11-27 | 8-K | 2012-11-14 | 1.01 Entry into a Material Definitive Agreement | 1.01 On November 14, 2012 we executed a consulting agreement with professor Camillo Ricordi. | form8k.htm |
| 2012-11-09 | 8-K | 2012-10-30 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 30, 2012 Orgenesis Inc. (the “Company”) and Fraunhofer Institute for Interfacial Engineering and Biotechnology (“Fraunhofer IGB”) entered into a service agreement to develop a pilot process to manufacture human autologous insulin-producing cell transplants based on the Orgenesis technology. | form8k.htm |
| 2012-10-09 | 8-K | 2012-10-05 | 1.02 Termination of a Material Definitive Agreement | form8k.htm | |
| 2012-08-03 | 8-K | 2012-08-02 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 The disclosure under Item 3.02 of this current report on Form 8-K is responsive to this Item and is hereby incorporated by reference. 3.02 We accepted a subscription agreement and on July 31, 2012 issued an aggregate of 500,000 units of our company to an off-shore investor at a price of $1.00 per unit for gross proceeds of $500,000. | form8k.htm |
| 2012-05-31 | 8-K | 2012-05-02 | 1.01 Entry into a Material Definitive Agreement | 1.01 Effective May 2, 2012 we entered into a letter agreement with the Investor Relations Group Inc. to provide investor relations to our company. | form8k.htm |
| 2012-05-31 | 8-K | 2012-05-23 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective May 23, 2012 our board of directors adopted and approved the Global Share Incentive Plan (2012). | form8k.htm |
| 2012-05-31 | 8-K | 2012-05-31 | 1.01 Entry into a Material Definitive Agreement | 1.01 On April 14, 2012 we executed a consulting agreement with G. Alexander Fleming. | form8k.htm |
| 2012-05-02 | 8-K | 2012-04-30 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 The disclosure under Item 1.01 of this current report on Form 8-K is responsive to this Item and is hereby incorporated by reference. 3.02 On April 30, 2012, we accepted a subscription agreement and issued an aggregate of 100,000 units of our company to an off-shore investor at a price of $1.00 per unit for gross proceeds of $100,000. | form8k.htm |
| 2012-04-25 | 8-K | 2012-04-24 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On April 24, 2012 we entered into an agreement with Etti Hanochi dated for reference April 6, 2012. 5.02 The disclosure under Item 1.01 of this current report on Form 8-K is responsive to this Item and is hereby incorporated by reference. | form8k.htm |
| 2012-04-23 | 8-K | 2012-04-17 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On April 17, 2012 we entered into an agreement with Yaron Adler. 5.02 The disclosure under Item 1.01 of this current report on Form 8-K is responsive to this Item and is hereby incorporated by reference. | form8k.htm |
| 2012-04-13 | 8-K | 2012-03-22 | 1.01 Entry into a Material Definitive Agreement | 1.01 On April 11, 2012 we announced the entry into an agreement between Tel Hashomer - Medical Research, Infrastructure and Services Ltd. and our Israeli subsidiary, Orgenesis Ltd., to perform a study of liver cells into pancreatic cells, at the facilities and using the equipment and personnel of the Chaim Sheba Medical Center of Israel under the supervision of our Chief Science Officer, Prof. | form8k.htm |
| 2012-04-05 | 8-K | 2012-04-02 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | g5874.txt | |
| 2012-03-22 | 8-K | 2012-03-21 | 4.01 Changes in Registrant's Certifying Accountant | g5840.txt | |
| 2012-03-16 | 8-K/A | 2011-08-31 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure | g5823.txt | |
| 2012-03-15 | 8-K | 2012-03-02 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | g5820.txt | |
| 2012-02-08 | 8-K | 2012-02-02 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.06 Change in Shell Company Status | g5745.txt |